Stockscreener 앱 받기
4.3001
36.46%
-2.9399
Allurion Technologies Inc 주식(ALUR)의 최신 뉴스
Allurion reports promising results from obesity treatment trial By Investing.com - Investing.com Canada
Allurion Announces Positive Topline Results From AUDACITY Trial - BioSpace
Allurion Technologies Enhances Financial Agreements and Governance - TipRanks
Allurion announces AUDACITY trial meets one co-primary endpoint, misses other - TipRanks
Allurion reports promising results from obesity treatment trial - Investing.com India
Allurion Technologies expands board, appoints new director - Investing.com
Allurion Technologies expands board, appoints new director By Investing.com - Investing.com Canada
Allurion Technologies Expands Board with New Appointment - MSN
Allurion Technologies, Inc. (ALUR) Loses -38.66% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - MSN
Allurion Technologies Inc. Withdraws the Device from the French Market - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss - Marketscreener.com
Allurion Technologies, Inc. Announces Expansion of AI Weight Loss Coach to Support Patients on GLP-1s - Marketscreener.com
Allurion Technologies Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Allurion Technologies, Inc. Announces an Expanded Commercial Agreement with Weight Doctors - Marketscreener.com
Certain Restricted stock units of Allurion Technologies Inc. are subject to a Lock-Up Agreement Ending on 27-SEP-2024. - Marketscreener.com
Allurion Technologies Inc. Announces Chief Financial Officer Changes - Marketscreener.com
Allurion Technologies, Inc. Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - Marketscreener.com
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance - Marketscreener.com
Allurion Receives Continued Listing Standards Notice from NYSE - Marketscreener.com
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024 - Marketscreener.com
Allurion Announces Three Scientific Presentations at the 40th Annual Meeting of the American Society for Metabolic and Bariatric Surgery - Marketscreener.com
Allurion Announces Publication of Meta-Analysis Demonstrating the Safety and Effectiveness of the Allurion Program for Weight Loss - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Continued Weight Loss at One Year On the Allurion Program - Marketscreener.com
Allurion Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion Technologies, Inc. Announces Submission of First Three Modules of Premarket Approval Application to the U.S. Food and Drug Administration for the Allurion Balloon - Marketscreener.com
Allurion Presents Data From Largest Ever Real-World Experience of 19,428 Patients at The Obesity Society’s Annual Conference - Marketscreener.com
Allurion Announces Publication of New Data Demonstrating Weight Loss in Adolescents Suffering from Obesity - Marketscreener.com
Allurion Technologies : Proxy Statement Form 8 K - Marketscreener.com
Allurion Technologies Inc. Appoints Brendan Gibbons as Its New Chief Legal Officer and Corporate Secretary - Marketscreener.com
Allurion Technologies, Inc. Announces Publication of New Data Demonstrating Continued Weight Loss at One Year on the Allurion Program - Marketscreener.com
Allurion Launches in the US with Its First AI-Native Compounded GLP-1 Program - Marketscreener.com
Allurion Technologies Inc. Announces the Appointment of Keith Johns to Its Board of Directors - Marketscreener.com
Allurion Technologies Inc. Appoints Ojas A. Buch as Chief Operating Officer - Marketscreener.com
Allurion Technologies Inc. Appoints Adrian Wild as Senior Vice President, International Commercial - Marketscreener.com
Allurion Technologies (NYSE:ALUR) Sees Large Volume IncreaseHere's Why - MarketBeat
Allurion Technologies Announces Reverse Stock SplitOn December 23, 2024, Allurion Technologies, Inc. (NYSE: ALUR) disclosed the approval of a reverse stock split during the 2024 Annual Meeting of Stockholders. The reverse stock split of the Company’s - Defense World
Allurion Technologies : Announces Reverse Stock Split Form 8 K - Marketscreener.com
Financial Review: Alphatec (NASDAQ:ATEC) versus Allurion Technologies (NYSE:ALUR) - Defense World
Allurion Technologies Stock Scheduled to Reverse Split on Friday, January 3rd (NYSE:ALUR) - Defense World
Allurion Technologies to implement reverse stock split - MSN
Allurion Technologies announces reverse stock split By Investing.com - Investing.com Nigeria
Allurion Details Reverse Stock Split - MENAFN.COM
Allurion Technologies Announces 1-for-25 Reverse Stock Split; Shares Fall Pre-Bell - Marketscreener.com
Allurion Technologies announces reverse stock split - Investing.com
Allurion Technologies, Inc. Announces Reverse Stock Split - Business Wire
Allurion Technologies shareholders approve key proposals - Investing.com
Allurion Technologies shareholders approve key proposals By Investing.com - Investing.com UK
Analyze Allurion Technologies Inc (NYSE: ALUR) Before Investing. - Stocks Register
Allurion gains NYSE compliance plan acceptance By Investing.com - Investing.com Canada
Allurion Technologies (NYSE:ALUR) vs. AVITA Medical (NASDAQ:RCEL) Head-To-Head Contrast - Defense World
ALURAllurion Technologies, Inc. Latest Stock News & Market Updates - StockTitan
Allurion gains NYSE compliance plan acceptance - Investing.com
Why Vision Marine Technologies Shares Are Trading Higher By 34%; Here Are 20 Stocks Moving Premarket - Benzinga
Allurion launches AI weight loss support GLP-1 drug programme - Yahoo Finance
Allurion launches compounded GLP-1 program as FDA aims to end access - Yahoo Finance
Allurion launches compounded GLP-1 program as FDA aims to ends access - Yahoo Finance
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program - Marketscreener.com
1.70%
2.88%
자본화:
|
볼륨(24시간):